Search

Your search keyword '"Anegg, Maria"' showing total 6 results
Start Over Author "Anegg, Maria"
6 results on '"Anegg, Maria"'

2. Functional Outcomes in Head and Neck Cancer Patients

Author

Riechelmann, Herbert, primary, Dejaco, Daniel, additional, Steinbichler, Teresa Bernadette, additional, Lettenbichler-Haug, Anna, additional, Anegg, Maria, additional, Ganswindt, Ute, additional, Gamerith, Gabriele, additional, and Riedl, David, additional

Published
2022
Full Text
View/download PDF

4. Persistent Head and Neck Cancer Following First-Line Treatment

Author

Steinbichler, Teresa, primary, Lichtenecker, Madeleine, additional, Anegg, Maria, additional, Dejaco, Daniel, additional, Kofler, Barbara, additional, Schartinger, Volker, additional, Kasseroler, Maria-Therese, additional, Forthuber, Britta, additional, Posch, Andrea, additional, and Riechelmann, Herbert, additional

Published
2018
Full Text
View/download PDF

6. Prognostic value of tumor volume in patients with head and neck squamous cell carcinoma treated with primary surgery.

Author

Dejaco, Daniel, Steinbichler, Teresa, Schartinger, Volker H., Fischer, Natalie, Anegg, Maria, Dudas, Jozsef, Posch, Andrea, Widmann, Gerlig, and Riechelmann, Herbert

Subjects
TUMOR prognosis, SQUAMOUS cell carcinoma, HEAD & neck cancer treatment, TUMOR surgery, RESPONSE rates, SURVIVAL analysis (Biometry), PATIENTS
Abstract

Abstract: Background: Tumor volume in head and neck squamous cell carcinoma (HNSCC) was mainly measured in nonsurgically treated patients. We analyzed the influence of tumor volume on complete response (CR), overall survival (OS), and clear surgical margins also in primarily surgically treated patients. Methods: In contrast‐enhanced CTs, the tumor volumes of patients with incident HNSCC were measured. Results: The tumor volumes of 259 patients were measured, of which 125 patients (48%) underwent primary surgery and 102 patients (84%) had clear margins. The tumor volume was not an independent factor for CR at the primary tumor site. Risk of death increased by 1.4% per mL of tumor volume (95% confidence interval [CI] 0.8%‐2.0%; P < .001). The OS was better in patients treated with primary surgery, if the tumor volume was ≤12 mL (P < .001). Risk of involved margins increased by 4.5% per mL of tumor volume (95% CI 0.9%‐8.3%; P = .003). The predicted probability of clear margins was ≥80% in tumor volumes ≤ 16 mL. Conclusion: The tumor volume had an impact on CR, OS, and clear margins. The tumor volume may also aid in selecting HNSCC treatment. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results